The interaction between LINC02159 and ALYREF improved YAP1 mRNA stability by enhancing its m5C modification, which increased its expression and activated the downstream Hippo and β-catenin pathways to promote NSCLC cell growth and metastasis. The gene discussed is ALYREF; the disease is non-small cell lung carcinoma.